This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Sabine Gratzer
Introduction
Sabine Gratzer is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of acute kidney injury. Her work exemplifies the intersection of innovation and healthcare.
Latest Patents
Gratzer holds a patent for the compound {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid. This compound is designed for use in the prevention or treatment of acute kidney injury (AKI). The patent also covers a pharmaceutically acceptable salt of this compound, along with its medicament and pharmaceutical composition.
Career Highlights
Sabine Gratzer is currently associated with Sanofi, a leading global healthcare company. Her role at Sanofi allows her to contribute to innovative solutions in medicine, particularly in addressing critical health issues such as AKI.
Collaborations
Throughout her career, Gratzer has collaborated with esteemed colleagues, including Véronique Briand and Thomas Huebschle. These collaborations have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Sabine Gratzer's work in developing treatments for acute kidney injury showcases her dedication to innovation in healthcare. Her contributions are vital in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile